首页> 外文OA文献 >Efficacy of memantine on cognitive functions of patients with moderate vascular dementia
【2h】

Efficacy of memantine on cognitive functions of patients with moderate vascular dementia

机译:美金刚对中度血管性痴呆患者认知功能的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction: Vascular dementia is a common condition for which there is no effective approved pharmacological treatment available. Absence of effective treatment creates a difficult situation for those suffering from the disease, their caregivers, and healthcare providers. The objective of this study is todetermine the Efficacy of Memantine on cognitive functions in patients with Moderate vascular dementia.Material and methods: This Case series study was carried out inthe Neurology Section of department of Medicine Ziauddin University and Hospitals North Nazimabad campus, Karachifrom 12th March 2010 to 11th March 2011.90 patients were included, who fulfilled the inclusion criteria after taking an informed consent. The SPSS version 11 was applied to the data. Results: There were 55 (59.1%) males and 38 (40.9%) females. Mean ± standard deviation age 69.7 ± 6.6 years, mean duration of symptoms was 1.76 ± 1.1 years. Baseline minimental examination score was 15.14 ± 3.1. Minimental score after 24 weeks of drug therapy was 17.14 ± 4.1. Efficiency was found in 62 (66.7%) patients. Conclusion: Memantine produced only a small benefit in cognition (of uncertain clinical significance) in patients with moderate vascular dementia. Data is insufficient to support widespread use of this drug in vascular dementia. Individual patient analysis is needed to identify subgroups of patients with vascular dementia who might benefit.
机译:简介:血管性痴呆是一种常见疾病,目前尚无有效的有效药理治疗方法。缺乏有效的治疗方法给那些患有该疾病的人,他们的照料者和医疗保健提供者带来了困难。这项研究的目的是确定美金刚对中度血管性痴呆患者认知功能的功效。材料和方法:本病例系列研究于3月12日在齐奥丁大学医学部神经病学科和卡拉奇北纳齐玛巴德校区医院进行。 2010年至2011年3月11日,共纳入90例患者,他们在征得知情同意后符合纳入标准。将SPSS版本11应用于数据。结果:男性为55(59.1%),女性为38(40.9%)。平均±标准差年龄为69.7±6.6岁,平均症状持续时间为1.76±1。1年。基线最小体检得分为15.14±3.1。药物治疗24周后的最低分数为17.14±4.1。在62名(66.7%)患者中发现有效率。结论:美金刚对中度血管性痴呆患者的认知(临床意义不确定)仅产生很小的益处。数据不足以支持该药在血管性痴呆中的广泛使用。需要进行个体患者分析,以确定可能有益的血管性痴呆患者亚组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号